Additive Therapeutic Effects of Mesenchymal Stem Cells and IL-37 for Systemic Lupus Erythematosus

BACKGROUND: Although mesenchymal stem cells (MSCs) might offer a promising strategy for treating SLE, their immunoregulatory plasticity makes their therapeutic effects unpredictable. Whether overexpressing IL-37, an IL-1 family member with immunosuppressive activity, might enhance the therapeutic ef...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Am Soc Nephrol
Main Authors: Xu, Jianyong, Chen, Jieting, Li, Wenlei, Lian, Wei, Huang, Jieyong, Lai, Baoyu, Li, Lingyun, Huang, Zhong
Format: Artigo
Jezik:Inglês
Izdano: American Society of Nephrology 2020
Teme:
Basic Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6935004/
https://ncbi.nlm.nih.gov/pubmed/31604808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2019050545
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki